Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 53, Issue 3, 2002, Pages 343-352

  Sallam, Al Sayed ^a   Khalil, Enam ^b   Ibrahim, Hussain ^c   Freij, Ibtisam ^d  

^a Research and Development Division   (Jordan)

^b UNIVERSITY OF JORDAN   (Jordan)

^c Arab Company for Drug Industries & Medical Appliances   (Jordan)

^d Hayat Pharmaceutical Industries   (Jordan)

Author keywords

Dissolution; Drug delivery; Drug release; Formulation; Furosemide; Glyceryl monooleate; GMO; Liquid crystal; Monoolein; Sustained release

Indexed keywords

CITRATE TRISODIUM; FOOD ADDITIVE; FUROSEMIDE; GLYCEROL OLEATE; GMORPHIC 80; MACROGOL 1000; MACROGOL 400; PHOSPHATE; POLYSORBATE 80; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; BIOAVAILABILITY; CRYSTAL; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; DRUG FORMULATION; DRUG MANUFACTURE; IN VITRO STUDY; MEMBRANE BINDING; PARTITION COEFFICIENT; PH; RABBIT; STOMACH; STOMACH JUICE; SUSTAINED RELEASE FORMULATION; TECHNIQUE; TEMPERATURE; THERMAL ANALYSIS;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; DIURETICS; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; FUROSEMIDE; GASTRIC MUCOSA; GLYCERIDES; RABBITS; SOLUBILITY; TISSUE ADHESIVES;

EID: 0036213402     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(02)00016-4     Document Type: Article

References (27)

1. Drug delivery from cubic and other lipid-water phases
2. Phase behavior of the lidocaine-monoolein-water system
3. A study of polar lipid drug carrier systems undergoing a thermoreversible lamellar-to-cubic phase transition
4. Bioadhesive properties of the monoolein water system
5. A cubic-phase oral drug delivery system for controlled release of AG337
6. A cubic phase delivery system composed of glyceryl monooleate and water for sustained release of water soluble drugs
7. In vitro peptide release from liquid crystalline buccal delivery systems
8. An investigation into the bioadhesive nature of Myverol 18-99
9. Monoglyceride based liquid crystalline topical drug delivery systems
10. Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease
11. Bioadhesive drug delivery systems 1. Characterization of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate
12. An investigation of the parameters influencing the bioadhesive properties of Myverol 18-99/water gels
13. Slow release furosemide in the treatment of mild to moderate hypertension
14. Controlled release furosemide microcapsules: preformulation studies
15. Formulation and comparative bioavailability of conventional and sustained release furosemide tablets
16. Biopharmaceutic evaluation of furosemide as a potential candidate for a modified release peroral dosage form
17. Development and evaluation of a monolithic floating dosage form for furosemide
18. Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites
19. An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations
20. Effects of electrostatic interaction on the phase stability and structures of cubic phases of monoolein/oleic acid mixture membranes
21. The in-vitro pH-dissolution dependence and in-vivo bioavailability of frusemide-PVP solid dispersions
22. Physicochemical characterization of furosemide modifications
23. Cubic phases for studies of drug partition into lipid bilayers
24. Binding of drugs to monoglyceride-based drug delivery systems
25. Dissolution rate of furosemide from polyethylene glycol solid dispersions
26. Relationship between the pH of the diffusion layer and the dissolution rate of furosemide
27. Drug compatibility with the sponge phases formed in monoolein, water and propylene glycol or polyethylene glycol